###begin article-title 0
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
The two-pore channel TPCN2 mediates NAADP-dependent Ca2+-release from lysosomal stores
###end article-title 0
###begin p 1
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 177 179 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 226 228 226 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 447 449 447 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 733 735 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 885 887 885 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1156 1158 1156 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1243 1245 1243 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1306 1308 1306 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1354 1356 1354 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1483 1485 1483 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Second messenger-induced Ca2+-release from intracellular stores plays a key role in a multitude of physiological processes. In addition to 1,4,5-inositol trisphosphate (IP3), Ca2+, and cyclic ADP ribose (cADPR) that trigger Ca2+-release from the endoplasmatic reticulum (ER), nicotinic acid adenine dinucleotide phosphate (NAADP) has been identified as a cellular metabolite that mediates Ca2+-release from lysosomal stores. While NAADP-induced Ca2+-release has been found in many tissues and cell types, the molecular identity of the channel(s) conferring this release remained elusive so far. Here, we show that TPCN2, a novel member of the two-pore cation channel family, displays the basic properties of native NAADP-dependent Ca2+-release channels. TPCN2 transcripts are widely expressed in the body and encode a lysosomal protein forming homomers. TPCN2 mediates intracellular Ca2+-release after activation with low-nanomolar concentrations of NAADP while it is desensitized by micromolar concentrations of this second messenger and is insensitive to the NAADP analog nicotinamide adenine dinucleotide phosphate (NADP). Furthermore, TPCN2-mediated Ca2+-release is almost completely abolished when the capacity of lysosomes for storing Ca2+ is pharmacologically blocked. By contrast, TPCN2-specific Ca2+-release is unaffected by emptying ER-based Ca2+ stores. In conclusion, these findings indicate that TPCN2 is a major component of the long-sought lysosomal NAADP-dependent Ca2+-release channel.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s00424-009-0690-y) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 479 481 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 668 670 668 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 778 780 778 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 1009 1011 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1109 1111 1109 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1293 1294 1293 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1296 1298 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1340 1342 1340 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1463 1465 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1494 1495 1494 1495 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1503 1505 1503 1505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1561 1563 1561 1563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1602 1604 1602 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1606 1608 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1657 1659 1657 1659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1737 1739 1737 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
Ca2+-release from intracellular stores is a fundamental cellular process that is involved in the control of numerous physiological functions including muscle contraction, secretion, cell motility, and control of immune response [3, 11]. Given the diversity and complexity of these processes, it does not come as a surprise that Ca2+-release is controlled by a complex array of signaling pathways and second messengers [19, 23, 29, 32]. NAADP is the latest entry in the list of Ca2+-releasing molecules [19, 20]. This molecule is synthesized in the cell by ADP cyclases by exchanging the nicotinamide moiety of NADP with nicotinic acid [21]. Notably, among all known Ca2+-releasing agents, NAADP is the most potent one acting in the low-nanomolar concentration range [14]. The Ca2+-releasing activity of NAADP was first discovered in the mid-1990s in acidic lysosome-related organelles of sea urchin eggs [20] and has since been demonstrated in many mammalian tissues and cell types [13, 17]. NAADP-mediated Ca2+-release is characterized by a number of characteristic features. First of all, NAADP-dependent Ca2+-release displays a characteristic bell-shaped dose-response curve with a peak in the low nanomolar concentration range and total loss of activity at high micromolar concentrations [8, 22]. Moreover, the native NAADP-dependent Ca2+-release channel is insensitive to NADP which differs from NAADP only by the replacement of a carboxyl by an amid group [15]. Finally, in contrast to IP3- and Ca2+/cADPR-sensitive stores, NAADP mainly seems to induce Ca2+-release from acidic lysosomal stores [10, 13], although in some cell types, NAADP-mediated Ca2+-release was also found in ER-derived stores, including the nuclear envelope [15]
###end p 6
###begin p 7
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 626 628 626 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
The molecular identity of the cellular NAADP receptor has been a matter of controversy [13, 17]. It was suggested that there may be no unique receptor for NAADP but that NAADP, like Ca2+ and cADPR, is an agonist of the ryanodine receptor (RyR) complex present in ER-derived calcium stores [15]. Other studies suggested that members of the transient receptor potential (TRP) channel family including TRPM2 [1] and TRPML1 [34] may be the cellular target protein of NAADP. However, the micromolar concentrations of NAADP required to fully activate these channel are one to two orders higher than those found for NAADP-mediated Ca2+-release in a variety of cells. Since none of the so-far analyzed proteins matches the hallmarks of native NAADP-sensitive release channels in a satisfying fashion, we hypothesized that the major receptor of NAADP may be formed by another not yet characterized protein.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
Cloning of TPCN1 and TPCN2
###end title 9
###begin p 10
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
For cloning of TPCN1, two cDNA fragments were amplified from mouse brain RNA by RT-PCR using the SuperScript III-One-Step Kit (Invitrogen; primers for fragment 1: TTA GAA ATG CCT CTG ATG GAA and ATG CTT TGA GGT GAA ATT CCC A; primers for fragment 2: CAG ACA GCA TTG GTT TGA TGA G and GTG GGG TTT CTT CCT AGT GGT CTC GAG CCT CAT ACC AGA CAC AGA CAC). Following restriction digests, the two fragments were assembled in pcDNA3 using the Hind III site in the 5' untranslated region, the central EcoR I site, and the Xho I site generated by PCR in the 3' untranslated region (fragment 1 = 1,413 bp, fragment 2 = 1,548 bp). For cloning of TPCN2, the complete open-reading frame was amplified from mouse brain RNA. The forward primer (GGC TGT GGT ACC GCC ACC ATG GCG GCA GAA GAG CAG C) binds to the 5' end and contains a Kozak consensus sequence and a Kpn I restriction site for cloning; the reverse Primer (GCC GCT CGA GAG GCC AGC ATC TCT GTC CTG) binds to the 3' untranslated region and contains a Xho I restriction site for cloning. After restriction digest with KpnI and XhoI, the 2,255-bp fragment was cloned into pcDNA3 vector (Invitrogen). All cloned sequences were verified by sequencing.
###end p 10
###begin title 11
Northern blot
###end title 11
###begin p 12
###xml 342 344 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse multiple tissue Northern blot (Applied Biosystems/Ambion, Austin, TX) containing 2 microg poly(A) RNA from heart, brain, liver, spleen, kidney, lung, thymus, testis, ovary, and embryo was hybridized with probes against TPCN1 and TPCN2. Probes covered the entire coding regions and were generated by random-primed labeling with a alpha32P-dCTP (Roche, Basel, Switzerland). The membrane was hybridized overnight in stringent conditions. After two washing steps, the hybridized probe was visualized with a phosphorimager after an exposure time of 24 h or using a film (Hyperfilm MP, GE Healthcare, Piscataway, NJ) after a radiographic exposure time of 14 days at -80degreesC. The same blot was probed subsequently with TPCN1 and TPCN2 probes. The blot was stripped between each hybridization with SDS-containing buffer.
###end p 12
###begin title 13
Production of TPCN2-specific antibodies
###end title 13
###begin p 14
###xml 11 17 <span type="species:ncbi:9986">rabbit</span>
Polyclonal rabbit antisera were raised against a peptide (CDILE EPKEE ELMEK LHKHP) corresponding to aa 707 to 725 of TPCN2 plus a N-terminal cystein. For affinity purification of antibodies, the peptide was coupled to SulfoLink Coupling Gel (Thermo Fisher Scientific, Walthan, USA) in a column. Serum was loaded onto column and washed. Bound antibodies were eluted with 100 mM Glycin-HCl pH 2.8 in 800 microl aliquots and immediately neutralized with Tris-base.
###end p 14
###begin title 15
Deglycosylation assay
###end title 15
###begin p 16
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
The glycosylation deficient TPCN2 mutant (N594Q/N601Q) was cloned using the QuickChange Kit (Stratagene, La Jolla, CA). The deglycosylation assay was performed as described previously [25]. Briefly, HEK293 cells were transfected with TPCN2, TPCN2N594Q/N601Q, or EGFP-TPCN1 using the calcium phosphate method and lysed; 10 microg of whole-cell lysates were incubated in the presence or absence of PNGase F or endoglycosidase H (both New England Biolabs, Ipswich, MA), according to the manufacturer's instruction. The protein denaturation was performed for 10 min at 45degreesC, the enzyme incubation for 1 h at 37degreesC. Cell lysates were then analyzed. Subsequently, proteins were subjected to Western blot analysis.
###end p 16
###begin title 17
Coimmunoprecipitation in HEK293 cells
###end title 17
###begin p 18
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 907 908 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 927 928 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 929 930 915 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
For coimmunoprecipitation experiments, TPCN2 and TPCN1 fusion proteins were generated with either myc tag fused at the N-terminus or with EGFP sequence fused at the N-terminus. For expression of recombinant proteins, HEK293 cells were transfected using the calcium phosphate method. Three days after transfection, HEK293 cells were lysed as described previously [30]. Equal amounts of protein (measured by Bradford assay) were incubated overnight at 4degreesC with 40 microl of protein A-Sepharose (GE Healthcare, Chalfont St. Giles, UK) and a specific antibody (Cell Signaling Technology, Beverly, MA) directed against the myc tag of examined proteins and 500 microl of buffer containing 50 mM Tris HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, and 50 mM Triton X-100, supplemented with PI. Beads were pelleted by centrifugation and washed three times with cold buffer containing 20 mM Tris HCl (pH 7.4), 5 mM MgCl2, 0.5 mM DTT, 20% (v/v) Glycerol supplemented with PI. Interacting proteins were visualized after boiling for 5 min in Laemmli sample buffer by SDS/PAGE, Western blot analysis, and ECL (GE Healthcare). The antibodies used were as follows: anti-GFP for detection of EGFP-TPCN2 fusion protein. An antibody against GST (GE Healthcare) was used as control.
###end p 18
###begin title 19
Immunocytochemistry
###end title 19
###begin p 20
###xml 256 257 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1742 1744 1732 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 215 219 <span type="species:ncbi:9913">calf</span>
###xml 1522 1527 <span type="species:ncbi:9606">Human</span>
For immunodetection, COS-7 cells grown on glass coverslips in a 24-well plate were transiently transfected with TPCN2 cDNA using Fugene 6 (Roche Diagnostics). Cells were cultured in DMEM supplemented with 10% fetal calf serum and kept at 37degreesC, 10% CO2 and fixed 1 or 2 days after transfection with 4% paraformaldehyde in PBS. Cells were permeabilized and blocked with 0.5% Triton X-100 and 5% Chemiblock (Millipore, Billerica, USA) in PBS. Cells were incubated with anti-TPCN2 (1:1000), anti-Myc (Cell Signaling, Danvers, MA; 1:1,000), anti-GFP (Clontech, Mountain View, USA; 1:500), anti-HA (Cell Signaling; 1:1000), anti-lamp1 (Abcam, Cambridge, USA; 1:250), and anti-Calnexin (Santa Cruz Biotechnology, Santa Cruz, USA; 1:100) primary antibodies in 2% Chemiblock (Millipore) and 0.3% Triton X-100 for 1 h. Then, cells were washed four times with PBS for 5 min each and incubated with AMCA (1:100), Cy2 (1:200), Cy3 (1:400), and Cy5 (1:400) secondary antibodies (all Jackson ImmunoResearch, West Grove, PA) in 2% Chemiblock (Millipore) for 1 h. Unbound antibodies were removed by three washing steps with PBS. For the staining of membranes and organelles, TRITC-WGA (membranes; 1:100; Sigma), Mitotracker Red CMX Ros (Mitochondria; 1:1,500; Invitrogen), and Hoechst 33342 (Nuclei; 0.4 microg/ml; Invitrogen) were used according to manufacturers' instructions. For visualization of lysosomes, in some experiments, a lamp1-EGFP fusion protein was co-expressed with TPCN2 (kind gift of Esteban C. Dell'Angelica, Dept Human Genetics, UCLA, USA). The glass coverslips were then mounted onto glass slides with Permafluor (Sigma, St. Louis, MO). Cells were visualized under a Zeiss LSM 510 laser confocal microscope as previously described [25].
###end p 20
###begin title 21
Cell surface expression
###end title 21
###begin p 22
To determine surface expression of TPCN2 in COS-7 cells, the HA epitope was inserted into the loop between the putative first and second transmembrane domains of TPCN2. Two mutagenic primers (GTC GGG AAC ATC GTA TGG GTA AGT CTT TGT GAA GGA AGA TGG G and TAC GAT GTT CCC GAC TAC GCA GAT GTG CGC TAC CGT TC) have been used to insert the hemagglutinin sequence (YPYDVPDYA) in frame between amino acid residues 92 and 93 of TPCN2 using the QuikChange Kit (Stratagene) according to the manufacturer's instruction. The sequence has been verified by sequencing. After transfection, cells were analyzed by immunocytochemistry as described above except for omitting the permeabilization step with Triton X-100 (nonpermeabilized cells). Control cells were treated equally but permeabilized.
###end p 22
###begin title 23
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Ca2+ imaging
###end title 23
###begin p 24
###xml 188 190 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 191 192 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 295 296 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 965 966 961 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1080 1082 1076 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1083 1084 1079 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1170 1171 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 1178 1179 1174 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1246 1247 1242 1243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1274 1275 1270 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1489 1490 1481 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1490 1493 1482 1485 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340</sub>
###xml 1494 1495 1486 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1495 1498 1487 1490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">380</sub>
###xml 1583 1585 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
Two days after transfection with TPCN2-EGFP or with the empty EGFP vector using Fugene 6 (Roche, Basel, Switzerland), HEK293 cells were loaded with Fura-2AM (5 microM) before measuring [Ca2+]i and subsequently placed in extracellular recording solution containing (in mM) 140 NaCl, 5 KCl, 3 MgCl2, 10 glucose, and 10 HEPES, pH 7.4. The fluorescence intensity of individual patch-clamped cells was monitored with a dual excitation fluorometric system using a Carl Zeiss Axiovert 135 fluorescence microscope equipped with a x40 Plan-Apochromat 1.3 oil objective. The monochromatic light source (Polychrom II, TILL-Photonics) was tuned to excite Fura-2 fluorescence at 340 nm (F340) and 380 nm (F380) with a sampling frequency of 0.5 Hz for 3 ms each. Emission was detected at 450-550 nm using a PCO SensiCam VGA camera (Kelheim, Germany) and recorded and analyzed using Tillvision (Till Photonics, Martinsried, Germany). For internal perfusion with NAADP, NADP, or IP3, Fura-2AM-loaded HEK293 cells were patched in standard whole-cell configuration. After establishing base line [Ca2+]i, the membrane was perforated, and the recording was continued in current clamp mode (I = 0) [4]. Patch pipette solution contained in mM-140 KCl, 10 HEPES, 1 MgCl2, and 0.05 BAPTA (pH 7.4) [6]. Fura-2 (pentapotassium salt, Invitrogen, Carlsbad, USA) was added to the standard internal solution at 7 microM in addition to preloading. Changes in Fura-2 fluorescence are reported as the fluorescence ratios (F340/F380) and are translated into apparent intracellular calcium concentration according to [16].
###end p 24
###begin title 25
Statistics
###end title 25
###begin p 26
###xml 38 39 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 82 83 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 244 245 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
All values are given as mean +/- SEM; n is the number of experiments. An unpaired t test was performed for the comparison between two groups. Significance was tested by ANOVA followed by Dunett test if multiple comparisons were made. Values of P < 0.05 were considered significant.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 40 42 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1a</xref>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">6</xref>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">5</xref>
###xml 878 879 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">6</xref>
###xml 1064 1066 1064 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1b</xref>
###xml 1179 1180 1179 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">2</xref>
###xml 1183 1184 1183 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">3</xref>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1b</xref>
###xml 1289 1290 1289 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">3</xref>
###xml 1571 1573 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1c</xref>
###xml 1575 1576 1575 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1675 1677 1675 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1986 1988 1986 1988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1d</xref>
###xml 2057 2058 2057 2058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">4</xref>
###xml 2589 2591 2589 2591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1d</xref>
###xml 3298 3300 3298 3300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1e</xref>
###xml 3434 3436 3434 3436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1e</xref>
###xml 3439 3445 3439 3445 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 3478 3479 3478 3479 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3479 3490 3479 3490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upper panel</italic>
###xml 3584 3593 3584 3593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red forks</italic>
###xml 3595 3606 3595 3606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 3816 3817 3816 3817 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3865 3875 3865 3875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 3888 3899 3888 3899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 3953 3954 3953 3954 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3967 3978 3967 3978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 3996 4007 3996 4007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 4075 4080 4075 4080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 4096 4099 4096 4099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 4117 4121 4117 4121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 4130 4139 4130 4139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bar</italic>
###xml 4151 4152 4147 4148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 4227 4237 4223 4233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 4257 4263 4253 4259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 4332 4343 4328 4339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 4395 4396 4391 4392 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 4480 4489 4476 4485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1&#8211;3</italic>
###xml 4534 4543 4530 4539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 6&#8211;8</italic>
###xml 4593 4600 4589 4596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 4602 4603 4598 4599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 4605 4606 4601 4602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 4630 4643 4626 4639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3 and 8</italic>
###xml 4680 4687 4676 4683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lanes 1</italic>
###xml 4689 4690 4685 4686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 4698 4704 4694 4700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 3445 4721 3445 4717 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Properties of two-pore channels. <bold>a</bold><italic>Upper panel</italic> Transmembrane topology of TPCN1 and TPCN2. The predicted N-glycosylation sites are marked by <italic>red forks</italic>. <italic>Lower panel</italic> Schematic representation of the primary sequence of TPCN1 and TPCN2. The degree of sequence identity within the N- and C-termini, the two transmembrane building blocks and the interdomain linker is indicated. <bold>b</bold> Mouse multiple tissue northern blots of TPCN1 (<italic>left panel</italic>) and TPCN2 (<italic>right panel</italic>) demonstrate expression in all tissues investigated. <bold>c</bold> EGFP-TPCN1 (<italic>upper panel</italic>) and EGFP-TPCN2 (<italic>lower panel</italic>) channels expressed in HEK293 cells are localized intracellularly (<italic>green</italic> TPCN channels; <italic>red</italic> membrane marker, <italic>blue</italic> nuclei; <italic>scale bar</italic> 5&#160;&#181;m). <bold>d</bold> Western blots with lysates from HEK293 cells containing myc-tagged TPCN1 (<italic>left panel</italic>), wild-type TPCN2 (<italic>middle</italic>) panel, and a glycosylation-deficient TPCN2 double-mutant (TPCN-2Q; <italic>right panel</italic>). Ten micrograms of protein were applied per lane. <bold>e</bold> Lysates of HEK293 cells cotransfected with myc-tagged TPCN2 and EGFP-tagged TPCN2 (<italic>lanes 1&#8211;3</italic>) or myc-tagged TPCN1 and EGFP-tagged TPCN2 (<italic>lanes 6&#8211;8</italic>) were immunoprecipitated with anti-myc antibody (<italic>lanes 2</italic>, <italic>5</italic>, <italic>7</italic>) or anti-GST (control, <italic>lanes 3 and 8</italic>), blotted and probed with anti-GFP. <italic>Lanes 1</italic>, <italic>6</italic> input, <italic>lane 4</italic> negative control</p>
###xml 3445 4721 3445 4717 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Properties of two-pore channels. <bold>a</bold><italic>Upper panel</italic> Transmembrane topology of TPCN1 and TPCN2. The predicted N-glycosylation sites are marked by <italic>red forks</italic>. <italic>Lower panel</italic> Schematic representation of the primary sequence of TPCN1 and TPCN2. The degree of sequence identity within the N- and C-termini, the two transmembrane building blocks and the interdomain linker is indicated. <bold>b</bold> Mouse multiple tissue northern blots of TPCN1 (<italic>left panel</italic>) and TPCN2 (<italic>right panel</italic>) demonstrate expression in all tissues investigated. <bold>c</bold> EGFP-TPCN1 (<italic>upper panel</italic>) and EGFP-TPCN2 (<italic>lower panel</italic>) channels expressed in HEK293 cells are localized intracellularly (<italic>green</italic> TPCN channels; <italic>red</italic> membrane marker, <italic>blue</italic> nuclei; <italic>scale bar</italic> 5&#160;&#181;m). <bold>d</bold> Western blots with lysates from HEK293 cells containing myc-tagged TPCN1 (<italic>left panel</italic>), wild-type TPCN2 (<italic>middle</italic>) panel, and a glycosylation-deficient TPCN2 double-mutant (TPCN-2Q; <italic>right panel</italic>). Ten micrograms of protein were applied per lane. <bold>e</bold> Lysates of HEK293 cells cotransfected with myc-tagged TPCN2 and EGFP-tagged TPCN2 (<italic>lanes 1&#8211;3</italic>) or myc-tagged TPCN1 and EGFP-tagged TPCN2 (<italic>lanes 6&#8211;8</italic>) were immunoprecipitated with anti-myc antibody (<italic>lanes 2</italic>, <italic>5</italic>, <italic>7</italic>) or anti-GST (control, <italic>lanes 3 and 8</italic>), blotted and probed with anti-GFP. <italic>Lanes 1</italic>, <italic>6</italic> input, <italic>lane 4</italic> negative control</p></caption>
###xml 4721 4721 4717 4717 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="424_2009_690_Fig1_HTML" id="MO1"/>
###xml 3439 4721 3439 4717 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="29">Properties of two-pore channels. <bold>a</bold><italic>Upper panel</italic> Transmembrane topology of TPCN1 and TPCN2. The predicted N-glycosylation sites are marked by <italic>red forks</italic>. <italic>Lower panel</italic> Schematic representation of the primary sequence of TPCN1 and TPCN2. The degree of sequence identity within the N- and C-termini, the two transmembrane building blocks and the interdomain linker is indicated. <bold>b</bold> Mouse multiple tissue northern blots of TPCN1 (<italic>left panel</italic>) and TPCN2 (<italic>right panel</italic>) demonstrate expression in all tissues investigated. <bold>c</bold> EGFP-TPCN1 (<italic>upper panel</italic>) and EGFP-TPCN2 (<italic>lower panel</italic>) channels expressed in HEK293 cells are localized intracellularly (<italic>green</italic> TPCN channels; <italic>red</italic> membrane marker, <italic>blue</italic> nuclei; <italic>scale bar</italic> 5&#160;&#181;m). <bold>d</bold> Western blots with lysates from HEK293 cells containing myc-tagged TPCN1 (<italic>left panel</italic>), wild-type TPCN2 (<italic>middle</italic>) panel, and a glycosylation-deficient TPCN2 double-mutant (TPCN-2Q; <italic>right panel</italic>). Ten micrograms of protein were applied per lane. <bold>e</bold> Lysates of HEK293 cells cotransfected with myc-tagged TPCN2 and EGFP-tagged TPCN2 (<italic>lanes 1&#8211;3</italic>) or myc-tagged TPCN1 and EGFP-tagged TPCN2 (<italic>lanes 6&#8211;8</italic>) were immunoprecipitated with anti-myc antibody (<italic>lanes 2</italic>, <italic>5</italic>, <italic>7</italic>) or anti-GST (control, <italic>lanes 3 and 8</italic>), blotted and probed with anti-GFP. <italic>Lanes 1</italic>, <italic>6</italic> input, <italic>lane 4</italic> negative control</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig1_HTML" id="MO1"/></fig>
###xml 4721 4727 4717 4723 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 4809 4810 4805 4806 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 4834 4839 4830 4835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 4953 4956 4949 4952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 4979 4980 4975 4976 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 5051 5052 5047 5048 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 5129 5132 5125 5128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d&#8211;f</bold>
###xml 5158 5163 5154 5159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 5201 5204 5197 5200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 5239 5240 5235 5236 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 5278 5279 5274 5275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 5314 5315 5310 5311 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 5318 5321 5314 5317 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g&#8211;i</bold>
###xml 5347 5352 5343 5348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 5365 5368 5361 5364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 5403 5404 5399 5400 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 5431 5432 5427 5428 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 5467 5468 5463 5464 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 5472 5476 5468 5472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bars</italic>
###xml 4727 5487 4723 5479 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">TPCN2 is localized in the lysosomes. Immunocytochemistry of TPCN2 in COS-7 cells. <bold>a</bold> Strong TPCN2 staining (<italic>green</italic>) is observed in intracellular compartments. By contrast, TPCN2 is absent from the plasma membrane (visualized in <italic>red</italic> by a specific maker). <bold>b</bold> After permeabilization, HA-tagged TPCN2 is detected intracellularily. <bold>c</bold> HA-tagged TPCN2 is not detected in the membrane of non permeabilized cells. <bold>d&#8211;f</bold> Colocalization of TPCN2 (<italic>green</italic>) and the ER marker protein calnexin (<italic>red</italic>). Most TPCN2-positive structures (<bold>d</bold>) costaine for endoplasmic reticulum (<bold>e</bold>), yielding yellow in the overlay (<bold>f</bold>). <bold>g&#8211;i</bold> Colocalization of TPCN2 (<italic>green</italic>) and lamp1 (<italic>red</italic>). Most TPCN2-positive structures (<bold>g</bold>) costained for lysosomes (<bold>h</bold>), yielding yellow in the overlay (<bold>i</bold>). (<italic>bars</italic> 10&#160;&#181;m)</p>
###xml 4727 5487 4723 5479 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">TPCN2 is localized in the lysosomes. Immunocytochemistry of TPCN2 in COS-7 cells. <bold>a</bold> Strong TPCN2 staining (<italic>green</italic>) is observed in intracellular compartments. By contrast, TPCN2 is absent from the plasma membrane (visualized in <italic>red</italic> by a specific maker). <bold>b</bold> After permeabilization, HA-tagged TPCN2 is detected intracellularily. <bold>c</bold> HA-tagged TPCN2 is not detected in the membrane of non permeabilized cells. <bold>d&#8211;f</bold> Colocalization of TPCN2 (<italic>green</italic>) and the ER marker protein calnexin (<italic>red</italic>). Most TPCN2-positive structures (<bold>d</bold>) costaine for endoplasmic reticulum (<bold>e</bold>), yielding yellow in the overlay (<bold>f</bold>). <bold>g&#8211;i</bold> Colocalization of TPCN2 (<italic>green</italic>) and lamp1 (<italic>red</italic>). Most TPCN2-positive structures (<bold>g</bold>) costained for lysosomes (<bold>h</bold>), yielding yellow in the overlay (<bold>i</bold>). (<italic>bars</italic> 10&#160;&#181;m)</p></caption>
###xml 5487 5487 5479 5479 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="424_2009_690_Fig2_HTML" id="MO2"/>
###xml 4721 5487 4717 5479 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="30">TPCN2 is localized in the lysosomes. Immunocytochemistry of TPCN2 in COS-7 cells. <bold>a</bold> Strong TPCN2 staining (<italic>green</italic>) is observed in intracellular compartments. By contrast, TPCN2 is absent from the plasma membrane (visualized in <italic>red</italic> by a specific maker). <bold>b</bold> After permeabilization, HA-tagged TPCN2 is detected intracellularily. <bold>c</bold> HA-tagged TPCN2 is not detected in the membrane of non permeabilized cells. <bold>d&#8211;f</bold> Colocalization of TPCN2 (<italic>green</italic>) and the ER marker protein calnexin (<italic>red</italic>). Most TPCN2-positive structures (<bold>d</bold>) costaine for endoplasmic reticulum (<bold>e</bold>), yielding yellow in the overlay (<bold>f</bold>). <bold>g&#8211;i</bold> Colocalization of TPCN2 (<italic>green</italic>) and lamp1 (<italic>red</italic>). Most TPCN2-positive structures (<bold>g</bold>) costained for lysosomes (<bold>h</bold>), yielding yellow in the overlay (<bold>i</bold>). (<italic>bars</italic> 10&#160;&#181;m)</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig2_HTML" id="MO2"/></fig>
###xml 201 221 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 247 250 <span type="species:ncbi:10116">rat</span>
###xml 312 315 <span type="species:ncbi:10116">rat</span>
###xml 433 439 <span type="species:ncbi:10090">murine</span>
###xml 490 496 <span type="species:ncbi:10090">Murine</span>
###xml 1000 1006 <span type="species:ncbi:10090">murine</span>
###xml 3818 3823 <span type="species:ncbi:10090">Mouse</span>
In our search for novel intracellular Ca2+-release channels, we analyzed mammalian homologs of the two-pore cation channel TPC1, a Ca2+-activated release channel identified in the vacuolar membrane of Arabidopsis thaliana and other plants [26]. A rat homolog of TPC1, designated TPCN1 was originally cloned from rat kidney but was not functionally characterized [18]. Based on sequence data from the gene bank, we cloned full-length murine TPCN1 and a novel homolog of this channel, TPCN2. Murine TPCN1 and TPCN2 show an overall sequence identity of about 20% to each other and to plant TPC1 [26] (Fig. 1a, Supplementary Fig. S1). TPCN channels represent a distinct branch within the superfamily of pore-loop channels [12, 31]. They are composed of two homologous building blocks each containing six transmembrane helices (S1-S6) and an ion-conducting pore loop between S5 and S6. The two putative pore loops of TPCN1 and TPCN2 show substantial homology to the pore of TPC1. In contrast to TPC1 both murine channels do not contain EF hand motifs that may act as Ca2+ sensors in TPC1. Transcripts of TPCN1 and TPCN2 are widely expressed in the body (Fig. 1b, Supplementary Figs. S2, S3) with expression levels of TPCN1 usually being higher than those of TPCN2 (Fig. 1b, Supplementary Fig. S3). The size of the detected mRNA transcripts corresponds well to the size of the predicted sequence (4,705 bp for TPCN1 and 2,909 bp for TPCN2). Upon heterologous expression in HEK293 or COS-7 cells, both TPCN1 and TPCN2 are strictly localized in intracellular compartments (Figs. 1c, 2). Removal of the cytosolic N- and C-termini, as well as deletion of cryptic ER retention signals [33], present in the primary sequences of TPCN1 or TPCN2 (dileucine motifs starting at position 8 and 692 and a RxR motive starting at position 313 in TPCN2) did not result in increased expression in the plasma membrane (not shown). Two protein bands were detected in immunoblots for either TPCN1 or TPCN2 (Fig. 1d, left lanes in left and middle panels, see also Supplementary Fig. S4 for generation and validation of the TPCN2 antibody). The respective lower bands represent the core-glycosylated proteins since they are shifted to slightly lower molecular weights after incubation with endo-glycosidase H (EndoH). The upper band corresponds to the fully glycosylated mature channel which is resistant to Endo H and is sensitive to treatment with N-glycosidase F (PNGase F). Mutation of the two putative N-glycosylation sites in TPCN2 (N594 and N601) resulted in the production of a non-glycosylated protein (Fig. 1d, right panel). The size of the non-glycosylated TPCN1 and TPCN2 proteins was smaller than predicted from the primary sequence (78.5 vs. 94.3 kDa for TPCN1 and 63 vs. 83.5 kDa for TPCN2). The apparent smaller molecular weight very likely arises from an aberrant gel mobility of the two proteins because it was also observed with EGFP-tagged TPCN channel proteins and with antibodies that were targeted to either N- or C-termini. Given the principal topology of pore-loop cation channels, it is very likely that two TPCN channel subunits assemble to form a complex with pseudo-tetrameric symmetry. Indeed, co-immunoprecipitation experiments showed that TPCN2 assembles with each other to form homomers (Fig. 1e). By contrast, TPCN2 did not form immunocomplexes with TPCN1 indicating that TPCN2-TPCN1 heteromers are not formed in the cell (Fig. 1e). Fig. 1Properties of two-pore channels. aUpper panel Transmembrane topology of TPCN1 and TPCN2. The predicted N-glycosylation sites are marked by red forks. Lower panel Schematic representation of the primary sequence of TPCN1 and TPCN2. The degree of sequence identity within the N- and C-termini, the two transmembrane building blocks and the interdomain linker is indicated. b Mouse multiple tissue northern blots of TPCN1 (left panel) and TPCN2 (right panel) demonstrate expression in all tissues investigated. c EGFP-TPCN1 (upper panel) and EGFP-TPCN2 (lower panel) channels expressed in HEK293 cells are localized intracellularly (green TPCN channels; red membrane marker, blue nuclei; scale bar 5 microm). d Western blots with lysates from HEK293 cells containing myc-tagged TPCN1 (left panel), wild-type TPCN2 (middle) panel, and a glycosylation-deficient TPCN2 double-mutant (TPCN-2Q; right panel). Ten micrograms of protein were applied per lane. e Lysates of HEK293 cells cotransfected with myc-tagged TPCN2 and EGFP-tagged TPCN2 (lanes 1-3) or myc-tagged TPCN1 and EGFP-tagged TPCN2 (lanes 6-8) were immunoprecipitated with anti-myc antibody (lanes 2, 5, 7) or anti-GST (control, lanes 3 and 8), blotted and probed with anti-GFP. Lanes 1, 6 input, lane 4 negative controlFig. 2TPCN2 is localized in the lysosomes. Immunocytochemistry of TPCN2 in COS-7 cells. a Strong TPCN2 staining (green) is observed in intracellular compartments. By contrast, TPCN2 is absent from the plasma membrane (visualized in red by a specific maker). b After permeabilization, HA-tagged TPCN2 is detected intracellularily. c HA-tagged TPCN2 is not detected in the membrane of non permeabilized cells. d-f Colocalization of TPCN2 (green) and the ER marker protein calnexin (red). Most TPCN2-positive structures (d) costaine for endoplasmic reticulum (e), yielding yellow in the overlay (f). g-i Colocalization of TPCN2 (green) and lamp1 (red). Most TPCN2-positive structures (g) costained for lysosomes (h), yielding yellow in the overlay (i). (bars 10 microm)
###end p 28
###begin p 29
###xml 33 34 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 34 45 34 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upper panel</italic>
###xml 139 148 139 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red forks</italic>
###xml 150 161 150 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 371 372 371 372 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 420 430 420 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 443 454 443 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 508 509 508 509 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 522 533 522 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 551 562 551 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 651 654 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 685 694 685 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bar</italic>
###xml 706 707 702 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 782 792 778 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 812 818 808 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 887 898 883 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 950 951 946 947 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1035 1044 1031 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1&#8211;3</italic>
###xml 1089 1098 1085 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 6&#8211;8</italic>
###xml 1148 1155 1144 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 1157 1158 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 1160 1161 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 1185 1198 1181 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3 and 8</italic>
###xml 1235 1242 1231 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lanes 1</italic>
###xml 1244 1245 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 1253 1259 1249 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 373 378 <span type="species:ncbi:10090">Mouse</span>
Properties of two-pore channels. aUpper panel Transmembrane topology of TPCN1 and TPCN2. The predicted N-glycosylation sites are marked by red forks. Lower panel Schematic representation of the primary sequence of TPCN1 and TPCN2. The degree of sequence identity within the N- and C-termini, the two transmembrane building blocks and the interdomain linker is indicated. b Mouse multiple tissue northern blots of TPCN1 (left panel) and TPCN2 (right panel) demonstrate expression in all tissues investigated. c EGFP-TPCN1 (upper panel) and EGFP-TPCN2 (lower panel) channels expressed in HEK293 cells are localized intracellularly (green TPCN channels; red membrane marker, blue nuclei; scale bar 5 microm). d Western blots with lysates from HEK293 cells containing myc-tagged TPCN1 (left panel), wild-type TPCN2 (middle) panel, and a glycosylation-deficient TPCN2 double-mutant (TPCN-2Q; right panel). Ten micrograms of protein were applied per lane. e Lysates of HEK293 cells cotransfected with myc-tagged TPCN2 and EGFP-tagged TPCN2 (lanes 1-3) or myc-tagged TPCN1 and EGFP-tagged TPCN2 (lanes 6-8) were immunoprecipitated with anti-myc antibody (lanes 2, 5, 7) or anti-GST (control, lanes 3 and 8), blotted and probed with anti-GFP. Lanes 1, 6 input, lane 4 negative control
###end p 29
###begin p 30
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 252 253 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 324 325 324 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 402 405 402 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d&#8211;f</bold>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 512 513 512 513 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 551 552 551 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 587 588 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 591 594 591 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g&#8211;i</bold>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 638 641 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 676 677 676 677 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 704 705 704 705 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 740 741 740 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 745 749 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bars</italic>
TPCN2 is localized in the lysosomes. Immunocytochemistry of TPCN2 in COS-7 cells. a Strong TPCN2 staining (green) is observed in intracellular compartments. By contrast, TPCN2 is absent from the plasma membrane (visualized in red by a specific maker). b After permeabilization, HA-tagged TPCN2 is detected intracellularily. c HA-tagged TPCN2 is not detected in the membrane of non permeabilized cells. d-f Colocalization of TPCN2 (green) and the ER marker protein calnexin (red). Most TPCN2-positive structures (d) costaine for endoplasmic reticulum (e), yielding yellow in the overlay (f). g-i Colocalization of TPCN2 (green) and lamp1 (red). Most TPCN2-positive structures (g) costained for lysosomes (h), yielding yellow in the overlay (i). (bars 10 microm)
###end p 30
###begin p 31
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2a</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">2</xref>
###xml 208 213 208 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2b, c</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2d&#8211;f</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2g&#8211;i</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">5</xref>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">6</xref>
We next analyzed the subcellular expression of heterologously expressed TPCN2 in COS-7 cells. Using wild-type TPCN2 (Fig. 2a) and TPCN2 channels carrying a HA tag in the linker region between S1 and S2 (Fig. 2b, c), we confirmed that the channel is expressed purely in intracellular compartments. Within the cell, TPCN2 was present in the ER (Fig. 2d-f) and colocalized with the lysosomal-associated membrane protein 1 (lamp1) that is a specific marker for acidic lysosomes (Fig. 2g-i, Supplementary Fig. S5). By contrast, there was no significant overlap of the TPCN2 signal with a mitochondrial marker (MitoTracker, Supplementary Fig. S6).
###end p 31
###begin p 32
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 347 349 347 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">4</xref>
###xml 590 592 590 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 626 627 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 698 699 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 767 769 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 813 818 809 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3a, c</xref>
###xml 832 834 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 870 871 864 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 917 919 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 988 990 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 992 994 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 1072 1073 1066 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1088 1090 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3b</xref>
###xml 1159 1161 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1181 1183 1175 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1222 1223 1216 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1238 1240 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3b</xref>
###xml 1351 1353 1345 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1363 1364 1357 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1497 1498 1491 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1500 1502 1494 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1510 1512 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3d</xref>
###xml 1738 1744 1732 1738 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1761 1763 1755 1757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1871 1873 1865 1867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1941 1942 1935 1936 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1990 1991 1984 1985 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1993 2004 1987 1998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 2044 2045 2038 2039 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2047 2058 2041 2052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 2147 2149 2141 2143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2159 2160 2153 2154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2162 2174 2156 2168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle panel</italic>
###xml 2181 2187 2175 2181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 2191 2192 2185 2186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2194 2195 2188 2189 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2234 2235 2228 2229 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2282 2283 2276 2277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2285 2286 2279 2280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2289 2290 2283 2284 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 2407 2415 2399 2407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brackets</italic>
###xml 2420 2421 2412 2413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2428 2429 2420 2421 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1744 2430 1738 2422 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">NAADP triggers Ca<sup>2+</sup>-release in HEK293 cells transfected with TPCN2. Application of 30&#160;nM NAADP via the patch pipette induces Ca<sup>2+</sup>-release from internal stores in cells transfected with TPCN2-EGFP (<bold>a</bold>) but not in cells transfected with EGFP alone (<bold>b</bold>, <italic>upper panel</italic>) or cells transfected with TPCN1-EGFP (<bold>b</bold>, <italic>lower panel</italic>). In cells transfected with TPCN2-EGFP, NADP (30&#160;nM; negative control) did not induce Ca<sup>2+</sup>-release (<bold>b</bold>, <italic>middle panel</italic>). The <italic>arrows</italic> in <bold>a</bold>, <bold>b</bold> indicate the start of cell perfusion. <bold>c</bold> Population data for experiments performed in (<bold>a</bold>, <bold>b</bold>). <bold>d</bold> Dose&#8211;response relationship of NAADP. All values are given as mean &#177; SEM. Number of cells measured is indicated in <italic>brackets</italic> in (<bold>c</bold>) and (<bold>d</bold>)</p>
###xml 1744 2430 1738 2422 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">NAADP triggers Ca<sup>2+</sup>-release in HEK293 cells transfected with TPCN2. Application of 30&#160;nM NAADP via the patch pipette induces Ca<sup>2+</sup>-release from internal stores in cells transfected with TPCN2-EGFP (<bold>a</bold>) but not in cells transfected with EGFP alone (<bold>b</bold>, <italic>upper panel</italic>) or cells transfected with TPCN1-EGFP (<bold>b</bold>, <italic>lower panel</italic>). In cells transfected with TPCN2-EGFP, NADP (30&#160;nM; negative control) did not induce Ca<sup>2+</sup>-release (<bold>b</bold>, <italic>middle panel</italic>). The <italic>arrows</italic> in <bold>a</bold>, <bold>b</bold> indicate the start of cell perfusion. <bold>c</bold> Population data for experiments performed in (<bold>a</bold>, <bold>b</bold>). <bold>d</bold> Dose&#8211;response relationship of NAADP. All values are given as mean &#177; SEM. Number of cells measured is indicated in <italic>brackets</italic> in (<bold>c</bold>) and (<bold>d</bold>)</p></caption>
###xml 2430 2430 2422 2422 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="424_2009_690_Fig3_HTML" id="MO3"/>
###xml 1738 2430 1732 2422 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="33">NAADP triggers Ca<sup>2+</sup>-release in HEK293 cells transfected with TPCN2. Application of 30&#160;nM NAADP via the patch pipette induces Ca<sup>2+</sup>-release from internal stores in cells transfected with TPCN2-EGFP (<bold>a</bold>) but not in cells transfected with EGFP alone (<bold>b</bold>, <italic>upper panel</italic>) or cells transfected with TPCN1-EGFP (<bold>b</bold>, <italic>lower panel</italic>). In cells transfected with TPCN2-EGFP, NADP (30&#160;nM; negative control) did not induce Ca<sup>2+</sup>-release (<bold>b</bold>, <italic>middle panel</italic>). The <italic>arrows</italic> in <bold>a</bold>, <bold>b</bold> indicate the start of cell perfusion. <bold>c</bold> Population data for experiments performed in (<bold>a</bold>, <bold>b</bold>). <bold>d</bold> Dose&#8211;response relationship of NAADP. All values are given as mean &#177; SEM. Number of cells measured is indicated in <italic>brackets</italic> in (<bold>c</bold>) and (<bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig3_HTML" id="MO3"/></fig>
The presence of TPCN2 in the ER and in lysomomes suggested that the protein may be a candidate for the NAADP-sensitive release channel [10, 13, 15]. In order to test this hypothesis, we measured calcium transients by using Fura-2 fluoresence in HEK293 cells (Fig. 3). Fluorescence was measured in the whole-cell patch-clamp configuration with a Ca2+-free extracellular solution to ensure that changes in fluorescence were due to intracellular release. Cells transfected with TPCN2 that was N-terminally fused with EGFP to monitor expression (Supplementary Fig. S4) showed a similar basal Ca2+ concentration (62.9 +/- 21.4 nM; n = 15) as control cells transfected with EGFP alone (50.6 +/- 19.5 nM; n = 8). Intracellular application of 30 nM NAADP produced a robust Ca2+ transient in TPCN2-transfected cells (Fig. 3a, c). The peak Ca2+ concentration was 292 +/- 54.9 nM (n = 28) which is in excellent agreement with Ca2+ concentrations obtained in native cells after stimulation by NAADP [24, 28]. By contrast, control cells transfected with EGFP did not respond to NAADP (P < 0.001; Fig. 3b, upper trace). Moreover, a close structural homolog of NAADP, NADP [15] did not yield a Ca2+ transient in TPCN2-transfected cells (P < 0.001; Fig. 3b, middle trace). Remarkably, cells transfected with a TPCN1-EGFP fusion protein displayed no NAADP-sensitive Ca2+-release (P < 0.001). The dose-response curve of TPCN2 for NAADP has the typical bell-shape described for the native mammalian release channel [8, 22] (Fig. 3d). The channel starts to get activated in the low nanomolar range of NAADP, reaches a peak at about 30 nM and inactivated at higher concentrations of NAADP. At micromolar NAADP concentrations, the channel is totally inactive. Fig. 3NAADP triggers Ca2+-release in HEK293 cells transfected with TPCN2. Application of 30 nM NAADP via the patch pipette induces Ca2+-release from internal stores in cells transfected with TPCN2-EGFP (a) but not in cells transfected with EGFP alone (b, upper panel) or cells transfected with TPCN1-EGFP (b, lower panel). In cells transfected with TPCN2-EGFP, NADP (30 nM; negative control) did not induce Ca2+-release (b, middle panel). The arrows in a, b indicate the start of cell perfusion. c Population data for experiments performed in (a, b). d Dose-response relationship of NAADP. All values are given as mean +/- SEM. Number of cells measured is indicated in brackets in (c) and (d)
###end p 32
###begin p 33
###xml 17 19 17 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 127 129 127 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 197 198 197 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 246 247 246 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 249 260 249 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 300 301 300 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 303 314 303 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 415 416 415 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 418 430 418 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle panel</italic>
###xml 437 443 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 447 448 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 490 491 490 491 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 538 539 538 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 541 542 541 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 545 546 545 546 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 663 671 661 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brackets</italic>
###xml 676 677 674 675 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 684 685 682 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
NAADP triggers Ca2+-release in HEK293 cells transfected with TPCN2. Application of 30 nM NAADP via the patch pipette induces Ca2+-release from internal stores in cells transfected with TPCN2-EGFP (a) but not in cells transfected with EGFP alone (b, upper panel) or cells transfected with TPCN1-EGFP (b, lower panel). In cells transfected with TPCN2-EGFP, NADP (30 nM; negative control) did not induce Ca2+-release (b, middle panel). The arrows in a, b indicate the start of cell perfusion. c Population data for experiments performed in (a, b). d Dose-response relationship of NAADP. All values are given as mean +/- SEM. Number of cells measured is indicated in brackets in (c) and (d)
###end p 33
###begin p 34
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 323 328 323 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4a, d</xref>
###xml 401 403 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 453 455 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 500 505 500 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4b, d</xref>
###xml 510 511 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 526 527 526 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 550 552 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 598 600 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 646 647 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 739 744 739 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4c, d</xref>
###xml 791 793 791 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1180 1186 1180 1186 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1219 1221 1219 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1246 1247 1246 1247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1392 1394 1392 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1404 1414 1404 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 1417 1425 1417 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red line</italic>
###xml 1456 1457 1456 1457 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1586 1588 1582 1584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1598 1608 1594 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 1611 1619 1607 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red line</italic>
###xml 1640 1641 1636 1637 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1644 1645 1640 1641 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1712 1714 1700 1702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1764 1774 1752 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 1788 1796 1776 1784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red line</italic>
###xml 1845 1851 1829 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 1856 1859 1840 1843 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;c</bold>
###xml 1899 1900 1883 1884 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1943 1946 1927 1930 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;c</bold>
###xml 1990 1998 1974 1982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brackets</italic>
###xml 2000 2002 1984 1986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 2017 2020 2001 2004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Baf</italic>
###xml 2034 2037 2018 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP3</italic>
###xml 1186 2123 1186 2107 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">TPCN2 mediates NAADP-dependent Ca<sup>2+</sup>-release from lysosomes. <bold>a</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (45&#160;min) with 100&#160;nM bafilomycin almost completely abolished NAADP (30&#160;nM)-induced Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> control without pretreatment. <bold>b</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (15&#160;min) with 1&#160;&#181;M thapsigargin did not reduce NAADP-sensitive Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> same control as in (<bold>a</bold>). <bold>c</bold> Effect of thapsigargin (1&#160;&#181;M) on the IP3 (3&#160;&#181;M)-induced Ca<sup>2+</sup>-release. Experiments were performed either with (<italic>black line</italic>) or without (<italic>red line</italic>) thapsigargin preincubation (1&#160;&#181;M; 15&#160;min). <italic>Arrows</italic> in (<bold>a&#8211;c</bold>) indicate the start of cell perfusion. <bold>d</bold> Population data for experiments shown in (<bold>a&#8211;c</bold>). Number of cells measured is indicated in <italic>brackets</italic>. <italic>Tg</italic> thapsigargin; <italic>Baf</italic> bafilomycin; <italic>IP3</italic> Inositol-1,4,5-trisphosphate. Fluorescent ratio were normalized for better comparison</p>
###xml 1186 2123 1186 2107 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">TPCN2 mediates NAADP-dependent Ca<sup>2+</sup>-release from lysosomes. <bold>a</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (45&#160;min) with 100&#160;nM bafilomycin almost completely abolished NAADP (30&#160;nM)-induced Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> control without pretreatment. <bold>b</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (15&#160;min) with 1&#160;&#181;M thapsigargin did not reduce NAADP-sensitive Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> same control as in (<bold>a</bold>). <bold>c</bold> Effect of thapsigargin (1&#160;&#181;M) on the IP3 (3&#160;&#181;M)-induced Ca<sup>2+</sup>-release. Experiments were performed either with (<italic>black line</italic>) or without (<italic>red line</italic>) thapsigargin preincubation (1&#160;&#181;M; 15&#160;min). <italic>Arrows</italic> in (<bold>a&#8211;c</bold>) indicate the start of cell perfusion. <bold>d</bold> Population data for experiments shown in (<bold>a&#8211;c</bold>). Number of cells measured is indicated in <italic>brackets</italic>. <italic>Tg</italic> thapsigargin; <italic>Baf</italic> bafilomycin; <italic>IP3</italic> Inositol-1,4,5-trisphosphate. Fluorescent ratio were normalized for better comparison</p></caption>
###xml 2123 2123 2107 2107 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="424_2009_690_Fig4_HTML" id="MO4"/>
###xml 1180 2123 1180 2107 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="35">TPCN2 mediates NAADP-dependent Ca<sup>2+</sup>-release from lysosomes. <bold>a</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (45&#160;min) with 100&#160;nM bafilomycin almost completely abolished NAADP (30&#160;nM)-induced Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> control without pretreatment. <bold>b</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (15&#160;min) with 1&#160;&#181;M thapsigargin did not reduce NAADP-sensitive Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> same control as in (<bold>a</bold>). <bold>c</bold> Effect of thapsigargin (1&#160;&#181;M) on the IP3 (3&#160;&#181;M)-induced Ca<sup>2+</sup>-release. Experiments were performed either with (<italic>black line</italic>) or without (<italic>red line</italic>) thapsigargin preincubation (1&#160;&#181;M; 15&#160;min). <italic>Arrows</italic> in (<bold>a&#8211;c</bold>) indicate the start of cell perfusion. <bold>d</bold> Population data for experiments shown in (<bold>a&#8211;c</bold>). Number of cells measured is indicated in <italic>brackets</italic>. <italic>Tg</italic> thapsigargin; <italic>Baf</italic> bafilomycin; <italic>IP3</italic> Inositol-1,4,5-trisphosphate. Fluorescent ratio were normalized for better comparison</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig4_HTML" id="MO4"/></fig>
In HEK293 and COS-7 cells, TPCN2 was localized in the ER and the lyosomes. We tested from which of these compartments the observed Ca2+-release was originating. Preincubation of the cells with bafilomycin, a specific blocker of the vacuolar type-H+ ATPase [5], almost completely abolished NAADP-mediated Ca2+-release (Fig. 4a, d). By contrast, when ER stores were depleted by preincubation with the Ca2+-ATPase inhibitor thapsigargin, NAADP-sensitive Ca2+-release was not significantly reduced (Fig. 4b, d). IP3 which opens IP3Rs in the ER induced Ca2+-release in control cells but did not evoke Ca2+ transients in thapsigargin-pretreated cells (P < 0.001), demonstrating that the ER is functionally intact in TPCN2 expressing cells (Fig. 4c, d). These findings indicate that the observed Ca2+-release in TPCN2 expressing cells arises from lysosomal stores while the channel in the ER is functionally silent. The reason for the lack of activity of the channel in the ER has to be determined. However, one may speculate that TPCN2 requires an acidic pH as present in the lysomes and/or the assembly with proteins specifically expressed in lysosomes to acquire biological activity. Fig. 4TPCN2 mediates NAADP-dependent Ca2+-release from lysosomes. a In HEK293 cells transfected with TPCN2-EGFP, preincubation (45 min) with 100 nM bafilomycin almost completely abolished NAADP (30 nM)-induced Ca2+-release (black line). Red line control without pretreatment. b In HEK293 cells transfected with TPCN2-EGFP, preincubation (15 min) with 1 microM thapsigargin did not reduce NAADP-sensitive Ca2+-release (black line). Red line same control as in (a). c Effect of thapsigargin (1 microM) on the IP3 (3 microM)-induced Ca2+-release. Experiments were performed either with (black line) or without (red line) thapsigargin preincubation (1 microM; 15 min). Arrows in (a-c) indicate the start of cell perfusion. d Population data for experiments shown in (a-c). Number of cells measured is indicated in brackets. Tg thapsigargin; Baf bafilomycin; IP3 Inositol-1,4,5-trisphosphate. Fluorescent ratio were normalized for better comparison
###end p 34
###begin p 35
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 218 228 218 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 231 239 231 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red line</italic>
###xml 270 271 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 400 402 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 412 422 408 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 425 433 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red line</italic>
###xml 454 455 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 458 459 454 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 526 528 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 578 588 566 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 602 610 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red line</italic>
###xml 659 665 643 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 670 673 654 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;c</bold>
###xml 713 714 697 698 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 757 760 741 744 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;c</bold>
###xml 804 812 788 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brackets</italic>
###xml 814 816 798 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 831 834 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Baf</italic>
###xml 848 851 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP3</italic>
TPCN2 mediates NAADP-dependent Ca2+-release from lysosomes. a In HEK293 cells transfected with TPCN2-EGFP, preincubation (45 min) with 100 nM bafilomycin almost completely abolished NAADP (30 nM)-induced Ca2+-release (black line). Red line control without pretreatment. b In HEK293 cells transfected with TPCN2-EGFP, preincubation (15 min) with 1 microM thapsigargin did not reduce NAADP-sensitive Ca2+-release (black line). Red line same control as in (a). c Effect of thapsigargin (1 microM) on the IP3 (3 microM)-induced Ca2+-release. Experiments were performed either with (black line) or without (red line) thapsigargin preincubation (1 microM; 15 min). Arrows in (a-c) indicate the start of cell perfusion. d Population data for experiments shown in (a-c). Number of cells measured is indicated in brackets. Tg thapsigargin; Baf bafilomycin; IP3 Inositol-1,4,5-trisphosphate. Fluorescent ratio were normalized for better comparison
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1159 1161 1159 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
Here, we show that TPCN2, a novel member of the two-pore cation channel family, displays the basic functional properties of the native NAADP-dependent Ca2+-release channel. TPCN2 transcripts are widely expressed in the body and have been found in all tissues and organs investigated. TPCN2 encodes a glycosylated 75 kD protein forming homomers. Given the principal transmembrane topology of pore-loop cation channels, it is very likely that two TPCN channel subunits assemble with each other to form a complex with pseudo-tetrameric symmetry. This finding is in principal agreement with the reported molecular mass of the NAADP receptor of approximately 120 kDa [2, 9] that roughly corresponds to a TPCN2 dimer. The TPCN2 protein is specifically localized in intracellular compartments and is totally absent from the plasma membrane. Within the cells, the protein was present in acidic lysosomes and in the ER. Since our functional studies strongly indicate that only the lysosomal fraction of TPCN2 is sensitive to NAADP, the presence of TPCN2 in the ER probably reflects an overexpression phenomenon, as reported for other proteins, including ion channels [27].
###end p 37
###begin p 38
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 546 548 546 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 771 773 771 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1139 1141 1139 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1258 1260 1258 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Several lines of evidence support the notion that TPCN2 is a key component of long-sought lysosomal NAADP receptor. First of all, TPCN2 is the first channel identified that responds to NAADP in the correct physiological concentration range (low nM) [14]. Secondly, as described for native channels, TPCN2 is inactivated by micromolar NAADP concentrations [8, 22]. Thirdly, the channel is insensitive to the NAADP homolog NADP [15]. Also, the homologous TPCN1 channel is totally insensitive to NAADP. Fourthly, the increase in the intracellular Ca2+ concentration in cells expressing TPCN2 was in the same range as described for native NAADP-release channels [24, 28]. Fifthly, TPCN2 is localized in the acidic lysosomes, the subcelluar organelles where NAADP-dependent Ca2+-release was originally described [10]. Importantly, TPCN2 activity is abolished by maneuvers that deplete the lysosomes [10, 13] indicating that the protein is fully operative in these organelles. By contrast, TPCN2 present in the ER was functionally silent. While we cannot exclude that TPCN2 requires assembly with another cellular protein to form a functional Ca2+-release channel, the simplest interpretation of our work is that TPCN2 itself forms the lysosomal NAADP-sensitive Ca2+-release channel. Further in vivo studies will be required to dissect the signaling cascades that control activation and modulation of TPCN2.
###end p 38
###begin title 39
Electronic supplementary material
###end title 39
###begin p 40
Below is the link to the electronic supplementary material. 
###end p 40
###begin p 41
(DOC 9495 kb)
###end p 41
###begin title 42
Acknowledgements
###end title 42
###begin p 43
###xml 61 66 <span type="species:ncbi:9606">Human</span>
Lamp1-EGFP was a kind gift of Esteban C. Dell'Angelica (Dept Human Genetics, UCLA; USA). This work was supported by the Deutsche Forschungsgemeinschaft (DFG).
###end p 43
###begin p 44
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes
###end article-title 46
###begin article-title 47
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Solubilization of receptors for the novel Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate
###end article-title 47
###begin article-title 48
The versatility and universality of calcium signalling
###end article-title 48
###begin article-title 49
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Nicotinic acid adenine dinucleotide phosphate mediates Ca2+ signals and contraction in arterial smooth muscle via a two-pool mechanism
###end article-title 49
###begin article-title 50
Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells
###end article-title 50
###begin article-title 51
Role of the inositol 1,4,5-trisphosphate receptor in Ca(2+) feedback inhibition of calcium release-activated calcium current (I(crac))
###end article-title 51
###begin article-title 52
NAADP mobilizes calcium from acidic organelles through two-pore channels
###end article-title 52
###begin article-title 53
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells
###end article-title 53
###begin article-title 54
NAADP binding to its target protein in sea urchin eggs requires phospholipids
###end article-title 54
###begin article-title 55
NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs
###end article-title 55
###begin article-title 56
Calcium signaling
###end article-title 56
###begin article-title 57
International Union of Pharmacology. L. Nomenclature and structure-function relationships of CatSper and two-pore channels
###end article-title 57
###begin article-title 58
The NAADP receptor: new receptors or new regulation?
###end article-title 58
###begin article-title 59
NAADP receptors
###end article-title 59
###begin article-title 60
NAADP mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors
###end article-title 60
###begin article-title 61
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
A new generation of Ca2+ indicators with greatly improved fluorescence properties
###end article-title 61
###begin article-title 62
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
NAADP: a universal Ca2+ trigger
###end article-title 62
###begin article-title 63
Molecular cloning of a novel form (two-repeat) protein related to voltage-gated sodium and calcium channels
###end article-title 63
###begin article-title 64
Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers
###end article-title 64
###begin article-title 65
A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose
###end article-title 65
###begin article-title 66
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
###end article-title 66
###begin article-title 67
NAADP: a new second messenger for glucose-induced Ca2+ responses in clonal pancreatic beta cells
###end article-title 67
###begin article-title 68
###xml 15 17 15 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
IP3 receptor/Ca2+ channel: from discovery to new signaling concepts
###end article-title 68
###begin article-title 69
###xml 50 52 50 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
NAADP induces pH changes in the lumen of acidic Ca2+ stores
###end article-title 69
###begin article-title 70
Role of subunit heteromerization and N-linked glycosylation in the formation of functional hyperpolarization-activated cyclic nucleotide-gated channels
###end article-title 70
###begin article-title 71
The vacuolar Ca2+-activated channel TPC1 regulates germination and stomatal movement
###end article-title 71
###begin article-title 72
A constitutively open potassium channel formed by KCNQ1 and KCNE3
###end article-title 72
###begin article-title 73
NAADP mobilizes calcium from the endoplasmic reticular Ca(2+) store in T-lymphocytes
###end article-title 73
###begin article-title 74
###xml 13 15 13 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate
###end article-title 74
###begin article-title 75
Switching off calcium-dependent inactivation in L-type calcium channels by an autoinhibitory domain
###end article-title 75
###begin article-title 76
The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis
###end article-title 76
###begin article-title 77
Modulation of the ryanodine receptor and intracellular calcium
###end article-title 77
###begin article-title 78
A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels
###end article-title 78
###begin p 79
Xiangang Zong and Michael Schieder contributed equally to this work.
###end p 79
###begin p 80
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 80
###begin p 81
The online version of this article (doi:10.1007/s00424-009-0690-y) contains supplementary material, which is available to authorized users.
###end p 81
###begin p 82
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">,</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-</italic>
###xml 140 142 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
Note added in proof: during the submission process, a paper was published presenting similar findings that TPCN2 mediates NAADP-dependent Ca2+-release from acidic organelles [7].
###end p 82

